[
    [
        {
            "time": "",
            "original_text": "沃森生物mRNA新冠疫苗实现“零”突破 保护持久性或超一年",
            "features": {
                "keywords": [
                    "沃森生物",
                    "mRNA",
                    "新冠疫苗",
                    "零突破",
                    "保护持久性"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "沃森生物mRNA新冠疫苗实现“零”突破 保护持久性或超一年",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "万联证券---医药生物行业跟踪报告：2021年一季度疫苗批签发数据跟踪报告【行业研究】",
            "features": {
                "keywords": [
                    "万联证券",
                    "医药生物",
                    "疫苗",
                    "批签发数据",
                    "跟踪报告"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "万联证券---医药生物行业跟踪报告：2021年一季度疫苗批签发数据跟踪报告【行业研究】",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 4,
                "Headline_Structure": 6,
                "Source_Recency": 3
            }
        },
        {
            "time": "",
            "original_text": "沃森生物年报被交易所问询 虚增业绩再添新证据？ 问询",
            "features": {
                "keywords": [
                    "沃森生物",
                    "年报",
                    "交易所问询",
                    "虚增业绩",
                    "新证据"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "沃森生物年报被交易所问询 虚增业绩再添新证据？ 问询",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 10,
                "Source_Recency": 8
            }
        }
    ]
]